A Retrospective Study on the Use of Chinese Patent Medicine in 24 Medical Institutions for COVID-19 in China

• Main Authors: Nan Zhang (Author), Nannan Shi (Author), Siyu Li (Author), Guoxiu Liu (Author), Yonglong Han (Author), Li Liu (Author), Xin Zhang (Author), Xiangwen Kong (Author), Bihua Zhang (Author), Wenpeng Yuan (Author), Yi Liu (Author), Deqiang Deng (Author), Minxia Zheng (Author), Ying Zhang (Author), Lihua Li (Author), Xiaoping Wang (Author), Jiankun Wu (Author), Xiaolan Lin (Author), Hua Nian (Author), Xiaohong Wu (Author), Hua Wang (Author), Fang Liu (Author), Hongli Wang (Author), Hongshun Wang (Author), Ying Liu (Author), Weixin Zeng (Author), Manqin Yang (Author), Yanping Wang (Author), Huaqiang Zhai (Author), Yongyan Wang (Author)
• Formato: Livro
• Publicado em: Frontiers Media S.A., 2020-11-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Objective: This research aims to analyze the application regularity of Chinese patent medicine during the COVID-19 epidemic by collecting the names of the top three Chinese patent medicines used by 24 hospitals in 14 provinces of China in four time periods (January 20-22, February 16-18, March 01-03...